Gene Query: TNFSF13B

Dataset Description Geneva Score
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 95.61
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 87.46
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 78.71
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 67.82
Argonaute proteins couple chromatin silencing to alternative splicing 67.82
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 52.9
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 50.02
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 50.02
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 49.82
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 47.91
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 45.4
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 44.88
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 41.51
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 38.63
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 38.63
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 35.34
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 35.19
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 35.19
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 34.01
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 34.01
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 33.9
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 33.34
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 31.84
RNA-Seq from human ILC transitional populations 31.84
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 30.73
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 28.7
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 27.51
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 26.89
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 26.87
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 25.56
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 25.49
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 24.64
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 24.18
RNA-seq analysis of AML cells in response to ASLAN003 23.63
Transcriptome analysis of kidney organoids 23.43
Fibroblasts in cholesteatoma activate osteoclasts. 22.86
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 22.36
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 21.97
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 21.74
TAF1 is critical for AE driven leukemogenesis 21.74
Sensing self and nonself circular RNAs 21.67
CircRNAome diversity in human mature B-cells, T-cells and monocytes 21.54
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 21.39
FBXW7 modulates stress response by post-translational modification of HSF1 20.55
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 20.55
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 20.3
Transcriptomic analysis of human tonsillar TFH subsets 20.2
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 20.05
Single-cell analysis of human kidney organoids 19.9
Macrophage Ad5f35 M2 Challenge 19.62
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 19.52
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 19.47
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 19.12
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 18.98
Generation and functional characterization of MDSC-like cells 18.82
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 18.33
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 18.1
Macrophage Ad5f35 PhenoMap 18.0
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 17.93
HNF1A deficiency impairs β-cell fate, granule maturation and function 17.32
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 17.14
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 17.12
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 17.01
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 16.77
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 16.14
Transcription control by the ENL YEATS domain in acute leukemia 15.9
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 15.9
RNA polymerase in pre-B-ALL cell lines 15.85
Effects of rFVIIIFc on human macrophages 15.8
oxLDL exposed trained monocytes 15.6
Transcriptomes of oxLDL exposed trained monocytes 15.6
MARCKS and lnc-MARCKS act as inflammation regulators 15.23
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 15.03
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 15.03
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 14.78
Transcriptomes of human monocytes after ex vivo exposure to uric acid 14.66
RNA-Seq in neutrophils from Antiphospholipid Syndrome 14.62
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 14.42
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 14.37
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 14.15
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 13.8
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 13.78
Human neutrophil genome during PMA- and E. coli encounter-induced activation 13.77
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 13.77
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 13.72
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 13.69
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 13.6
Tracing Enhancer Networks using Epigenetic Traits (TENET) 13.43
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 13.42
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 13.29
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 13.22
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 13.22
SRSF2 mutations impair hematopoiesis and alter exon recognition 13.1
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 12.96
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 12.84
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 12.84
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 12.81
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 12.8
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 12.6
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 12.6
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 12.49
MicroRNA-125a-5p overexpression in human macrophages 12.42
Gene expression signatures of innate lymphoid cells from human blood 12.39
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 12.24
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 12.17
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 11.96
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 11.83
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 11.73
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 11.69
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.67
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 11.66
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 11.64
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 11.62
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.49
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 11.48
Efficient derivation of microglia-like cells from human pluripotent stem cells 11.34
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 11.33
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.32
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 11.2
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 11.13
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 11.12
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 11.1
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 11.08
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 11.02
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 10.97
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 10.91
Tpl-2 and MEK small molecule inhibitors 10.9
Tpl-2 small molecule project 10.9
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 10.87
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 10.8
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 10.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.66
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 10.65
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 10.65
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 10.63
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.46
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.39
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.39
Intrahepatic MAIT cell gene expression revealed by RNA-seq 10.26
Polarized B -cell functions 10.06
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.03
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.03
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 10.0
Regulatory network controlling tumor-promoting inflammation in human cancers 9.95
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 9.95
Transcriptional profile in human S. haematobium infection 9.93
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 9.81
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 9.74
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.6
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 9.31
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 9.23
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.22
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.99
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 8.97
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.89
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.89
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 8.83
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 8.7
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 8.65
Landscape and variation of RNA secondary structure across the human transcriptome 8.45
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.38
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.38
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 8.36
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 8.35
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 8.32
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 8.27
Ro60-knockout cells 8.24
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 8.13
Identification of renal resident macrophages across species 8.02
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 7.97
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 7.91
LncRNA expression profiling of ischemic stroke patients 7.89
RNA expression analysis upon JMJD1C depletion 7.78
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 7.78
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 7.78
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 7.68
Next generation sequencing of small RNAs isolated from exosomes in human semen 7.68
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 7.64
Direct Isolation and Characterization of Human Nephron Progenitors. 7.6
RNA-seq of MCF10A cells and CAF 7.54
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 7.51
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.45
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 7.44
RNA-seq of stable and unstable section of human atherosclerotic plaques 7.42
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 7.27
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 7.21
NAPRT activation of macrophages 7.18
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 7.12
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.1
Molecular Mechanisms of Endothelial Hyperpermeability 7.05
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 6.94
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 6.91
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 6.89
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 6.89
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.82
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 6.76
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 6.75
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 6.72
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 6.7
MAIT cell RNA sequencing 6.59
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 6.55
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.46
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 6.45
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 6.45
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.39
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 6.37
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 6.37
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 6.37
RNA-seq of Single-Cell Genotyping of Transcriptomes 6.19
Single-Cell Genotyping of Transcriptomes 6.19
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.19
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 6.17
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.16
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.14
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 6.13
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.1
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 6.05
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 6.05
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.04
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.97
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 5.95
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 5.92
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 5.9
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 5.85
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.8
Intron retention induced by microsatellite expansions as a disease biomarker. 5.76
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 5.75
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 5.74
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 5.74
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.74
Cleavage Factor Im as a key regulator of 3’ UTR length 5.73
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.67
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.67
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.55
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 5.4
HNF1 regulates critical functions of the human epididymis epithelium. 5.37
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.37
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 5.31
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 5.31
Genome-wide mapping of TEL-AML1 targets in acute leukemia 5.27
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.26
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 5.18
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 5.15
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 5.15
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 5.15
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 5.15
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 5.14
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.12
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.04
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 5.02
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.94
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.92
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.92
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 4.91
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.89
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.85
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 4.83
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.83
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 4.77
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 4.7
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.64
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.64
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.55
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.55
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 4.55
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.52
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.5
Dysregulated immune system networks in war veterans with PTSD 4.43
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.35
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.33
Reprogrammed myeloid cell transcriptomes in NSCLC 4.3
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.3
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 4.29
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.27
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.26
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 4.17
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 4.16
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 4.14
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 4.14
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 4.12
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 4.12
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 4.04
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.04
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.99
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.96
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.93
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.93
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.91
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 3.88
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.85
Trascriptome of thyroid cancer-induced macrophages 3.82
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 3.7
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 3.69
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.68
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.67
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 3.64
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 3.6
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.58
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.55
Aging-associated patterns in the expression of human endogenous retroviruses 3.53
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.47
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.44
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 3.39
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.35
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.32
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.32
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 3.29
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 3.28
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 3.28
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 3.25
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.23
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 3.2
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.15
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 3.08
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.06
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.05
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 3.04
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.04
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 3.02
Global analysis of enhancer targets: Mosaic-seq 3.0
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.0
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.95
The transcriptome of Kawasaki Disease arteritis 2.91
Human Tfh cell RNA bulk sequencing 2.88
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.85
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.83
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 2.82
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.78
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.76
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.76
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.73
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.73
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.69
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.69
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 2.68
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.67
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.64
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.64
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 2.63
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.61
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.57
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.57
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.55
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.5
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.49
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.49
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 2.49
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.46
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.44
Microglia innatly develop within cerebral organoids 2.42
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 2.38
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.35
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.27
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.24
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 2.23
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.22
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 2.21
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 2.17
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 2.14
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 2.14
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.14
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.14
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 2.12
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.11
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.1
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 2.1
METTL3 and WTAP 2.07
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.07
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.04
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.98
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.97
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.97
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.97
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.95
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.93
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.9
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.88
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.87
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.87
Gene expression profiling of KSHV-infected periodontal ligament cells 1.87
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.86
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.85
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.83
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.83
Metastasis in triple-negative breast cancer 1.83
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.79
Role of cervicovaginal microbiota in genital inflammation 1.78
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.76
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.69
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.67
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.67
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.64
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 1.64
SLAM-seq for K562 endogenous mRNA decay 1.62
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.6
RNA-seq data 1.6
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.6
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.58
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.57
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.55
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.53
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.52
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.49
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.44
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.4
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.39
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.38
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.37
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.34
Neonatal and adult human testis defined at the single-cell level 1.33
Bone marrow derived human B cells [normal proB] 1.32
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.31
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.3
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.24
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.16
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.16
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.15
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.14
The DNA methylation landscape of human melanoma [RNA-Seq] 1.14
The DNA methylation landscape of human melanoma 1.14
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.09
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.09
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.07
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.07
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.04
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.04
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.04
Expression analysis of the TAF1 syndrome 1.03
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.02
Characterization of human ILC2 subsets 0.99
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.99
KSDM1b Role in Ewing Sarcoma 0.97
Single-cell analysis of adult human ovary using 10X genomics 0.95
Transcriptome of Stabilin-1 siRNA transfected human monocytes 0.94
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.92
Transcription elongation regulates genome 3D structure 0.92
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.91
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.88
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.88
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.87
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.83
Leucegene: AML sequencing (part 6) 0.83
miR-93 Targets in Human Endothelial Cells 0.82
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.82
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.77
RNA-seq of primary patient AML samples 0.75
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.73
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.67
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.67
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.66
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.66
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.65
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.62
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.62
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.59
A single-cell transcriptome atlas of the human pancreas 0.58
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.54
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.53
MARS Seq data from human cortical organoids 0.53
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.51
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.5
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.5
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.49
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.45
Transcriptomic analysis of human macrophages in 3D 0.43
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.42
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.4
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.4
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.39
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.37
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.36
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 0.33
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.32
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.32
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.3
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.28
Transcriptome analysis of peripheral blood monocytes 0.27
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.26
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.26
Interphase condensins regulate ligand-depedent enhancer activation 0.26
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.25
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.21
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.21
Specific molecular signatures underlie response to decitabine in CMML 0.2
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.2
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.18
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.18
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.14
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.12
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.11
RNA-seq of CD33 KO and control HSPCs 0.1
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.09
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 0.09
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 0.08
A single cell reference map for human blood and tissue T cell activation 0.03
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation